Bruce G. Allen Investments LLC Invests $84,000 in Humana Inc. (NYSE:HUM)

Bruce G. Allen Investments LLC bought a new stake in shares of Humana Inc. (NYSE:HUMFree Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 184 shares of the insurance provider’s stock, valued at approximately $84,000.

Several other large investors have also recently bought and sold shares of HUM. Sunbelt Securities Inc. acquired a new position in Humana during the 1st quarter valued at $28,000. WFA of San Diego LLC acquired a new position in shares of Humana in the 2nd quarter valued at $29,000. Baystate Wealth Management LLC raised its stake in shares of Humana by 84.1% in the 2nd quarter. Baystate Wealth Management LLC now owns 81 shares of the insurance provider’s stock valued at $37,000 after buying an additional 37 shares in the last quarter. Householder Group Estate & Retirement Specialist LLC acquired a new position in shares of Humana in the 3rd quarter valued at $39,000. Finally, Nvwm LLC raised its stake in shares of Humana by 41.0% in the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after buying an additional 25 shares in the last quarter. 91.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on HUM shares. Royal Bank of Canada lowered their target price on shares of Humana from $507.00 to $415.00 and set an “outperform” rating on the stock in a report on Friday, January 26th. Wells Fargo & Company lowered their target price on shares of Humana from $465.00 to $413.00 and set an “overweight” rating on the stock in a report on Tuesday, January 30th. Mizuho decreased their price objective on shares of Humana from $550.00 to $400.00 and set a “buy” rating on the stock in a report on Friday, January 26th. Barclays began coverage on shares of Humana in a report on Wednesday, March 6th. They set an “equal weight” rating and a $356.00 price objective on the stock. Finally, Truist Financial reissued a “hold” rating and set a $550.00 price objective on shares of Humana in a report on Friday, January 19th. Nine equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $494.00.

Read Our Latest Stock Analysis on Humana

Insider Transactions at Humana

In other Humana news, Director Jorge S. Mesquita acquired 545 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were acquired at an average price of $367.09 per share, with a total value of $200,064.05. Following the completion of the transaction, the director now directly owns 2,578 shares in the company, valued at approximately $946,358.02. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.29% of the stock is currently owned by insiders.

Humana Stock Performance

Shares of HUM stock opened at $351.39 on Wednesday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.59 and a current ratio of 1.59. The company has a market capitalization of $42.40 billion, a P/E ratio of 17.73, a price-to-earnings-growth ratio of 2.04 and a beta of 0.45. The company’s 50 day moving average price is $374.20 and its two-hundred day moving average price is $447.49. Humana Inc. has a 52 week low of $334.54 and a 52 week high of $541.21.

Humana (NYSE:HUMGet Free Report) last announced its earnings results on Thursday, January 25th. The insurance provider reported ($0.11) EPS for the quarter, missing the consensus estimate of $0.76 by ($0.87). Humana had a return on equity of 19.44% and a net margin of 2.34%. The company had revenue of $26.46 billion for the quarter, compared to analyst estimates of $25.47 billion. During the same quarter last year, the business posted $1.62 earnings per share. The business’s quarterly revenue was up 17.9% on a year-over-year basis. On average, analysts expect that Humana Inc. will post 16.05 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date of this dividend is Wednesday, March 27th. Humana’s dividend payout ratio is presently 17.86%.

Humana Company Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Further Reading

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.